Opko Health, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Key investors, including OPKO Health and entities controlled by Dr. Phillip Frost, have collectively increased their beneficial ownership in Cocrystal Pharma, Inc., signaling strong conviction in the company's prospects.
NASDAQ
Phillip Frost, M.D. and associated entities have amended their Schedule 13D filing for OPKO Health, Inc., reporting a combined beneficial ownership of approximately 34.1% of the company's outstanding common stock.
NASDAQ
Dr. Phillip Frost and affiliated entities updated their beneficial ownership in OPKO Health, Inc. to 32.8% of outstanding common stock.
NASDAQ
SCHEDULE 13D/A: Dr. Phillip Frost and Affiliated Trusts Reaffirm Significant Stake in OPKO Health, Inc. with Latest SEC Filing
Dr. Phillip Frost and his affiliated trusts have filed Amendment No. 26 to their Schedule 13D, reaffirming their substantial beneficial ownership of 31.7% in OPKO Health, Inc., primarily due to a change in the issuer's outstanding shares.
NASDAQ
SCHEDULE 13D/A: OPKO Health Insider Dr. Jane Hsiao's Stake Dips Below 5% Threshold Due to Increased Outstanding Shares
Dr. Jane Hsiao's beneficial ownership in OPKO Health, Inc. has decreased to 4.48% from above 5%, triggering a Schedule 13D amendment, primarily due to an increase in the Issuer's total outstanding common stock.